Additionally, our analysis lacked plasma samples at multiple time-points throughout the acute and convalescent dengue phases, limiting our ability to determine the temporal trends of ANGPTL4 levels during the progression from mild to moderate to severe dengue. This evidence concerns the gene ANGPTL4 and dengue disease.